AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial Post author:Sam Post published:January 25, 2018 Post category:BioPharma Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace You Might Also Like EnXray Raises ??2.3 Million To Fund Commercial Launch April 9, 2017 Founding CEO of Editas Medicine Lands New Gig at Top Biotech VC Firm May 31, 2017 Invenra Appoints Vice President, Corporate Development May 15, 2017
